Sign in

Ineos Oxford Institute for antimicrobial research

@ineosoxford.bsky.social
703 followers 176 following 299 posts

Bringing together the best of research and industry to overcome one of the biggest threats facing humanity.

PostsRepliesMedia
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 14h
A new IOI research programme has received a £1M Oxford Martin School to advance antifungal discovery. The team will study bdelloid rotifers to identify promising new antifungal compounds. Read more :👉 ow.ly/gq4650ZUYm1
000
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 30/09/2026
This May, researchers at the IOI identified a new type of compound that could help to defend crucial 'last-resort' antibiotics from antimicrobial resistance (#AMR). 🔗Read more on our website: ow.ly/bvYm50ZOMcc
111
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 25/09/2026
At the EMBO workshop held at the Institut Pasteur, Oxford researchers Rachel Tanner and Philip Fowler shared their latest research exploring new approaches to tackle drug-resistant tuberculosis. Their work is a key part of the IOI's Grand Challenge for TB. Find out more🔗 ow.ly/UIXf50ZRmE7
Woman in a patterned blouse speaking at a podium with a microphone during a presentation or conference.Two women standing at a podium, one smiling while the other looks focused, both wearing conference badges and microphones nearby.Speaker presenting on AI and modeling to address mycobacterial infections at a conference session.
120
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 24/09/2026
Earlier this year, IOI researchers completed data collection on two large global studies on AMR impacts in LMICs. They gathered >24,000 bacterial isolates from patients around the world, and future analysis will help to track the spread of AMR worldwide. 🔗https://ow.ly/TQWi50ZKFJp
130
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 22/09/2026
In IOI's chemistry labs, Dr Xin (Damon) Wen is building new molecules that have the potential to become future antibiotics against multidrug-resistant bacteria. Read more about his work alongside other IOI scientists to develop new generations of β-lactams on our website 👉 ow.ly/cPky50ZP8QG
120
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 17/09/2026
A $16 blood test almost halved antibiotic use in adults hospitalised with sepsis in Bangladesh. The PROCALBAN trial led by Oxford’s Nuffield Department of Medicine found treatment duration fell from 9 to 5 days, helping reduce antibiotic exposure. 🔗 Read more: ow.ly/l6Ie50ZObhE
110
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 14/09/2026
Researchers at the IOI have received a grant from the Frances and Augustus Newman Foundation to study if existing antibiotics can be 'rescued' to extend their effectiveness against tuberculosis. 🔗Read more: www.ineosoxford.ox.ac.uk/news/new-f…
120
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 10/09/2026
To trace bacterial evolution without physical fossils, Oxford DPhil student Priyanshu Raikwar studies "genomic fossils" hidden in modern DNA. Mapping how ancient bacteria adapted to environmental shifts reveals how they develop resistance to antibiotics today. 🔗Read more: ow.ly/ncTG50ZL9tL
120
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 07/09/2026
In April, the Ineos Oxford Institute for antimicrobial research (IOI) established a new antifungal drug discovery programme to tackle the global threat of antifungal resistance - associated with >3.8 million deaths a year. 🔗Read more here: ow.ly/ufHk50ZIkJG
011
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 06/08/2026
Flash talk video - IOI ECR Conference 2026 Adam Roberts from the UK Health Security Agency shared findings on the repression of efpA in M. tuberculosis to reducing viability and preventing bacterial regrowth following isoniazid exposure. 👉Watch talk: ow.ly/Oip250YT8jT
000
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 30/07/2026
At our Early Career Researcher conference 2026, Oluwafemi Adewusi from the University of Kent gave a talk on his research into gender differences and sociocultural determinants of non-prescription antibiotic use in Southwestern Nigeria. 👉Watch his talk: ow.ly/1Yce50YT8cv
000
Reposted by Ineos Oxford Institute for antimicrobial research
MPLS Division, University of Oxford @mplsoxford.bsky.social · 29/07/2026
RESEARCH: @ineosoxford.bsky.social study shows the expansion of industrial poultry farming has increased the movement of Campylobacter more than 100-fold. The findings show how bacteria can spread and evolve in commercial flocks, with implications for AMR. ➡️ Read more: tinyurl.com/32enfhck
Chickens behind wire; headline: industrial chicken farms accelerate spread of a major foodborne disease.

Image credit:  Franz W
143
Reposted by Ineos Oxford Institute for antimicrobial research
Sky News @news.sky.com · 27/07/2026
Industrial poultry farming leads to 100-fold increase in food-poisoning bacteria, study finds
news.sky.com
Industrial poultry farming leads to 100-fold increase in food-poisoning bacteria, study finds
Industrial poultry farming has led to a more than 100-fold increase in the spread of a bacteria causing food poisoning, scientists have discovered.
31713
Reposted by Ineos Oxford Institute for antimicrobial research
The Guardian @theguardian.com · 27/07/2026
Industrial chicken farming accelerating spread of diarrhoea bacteria, study finds
theguardian.com
Industrial chicken farming accelerating spread of diarrhoea bacteria, study finds
Intensive nature of modern chicken farming creates ideal conditions for campylobacter, allowing bacteria to evolve Industrial chicken farming is accelerating the spread of the world’s most common bacterial cause of diarrhoea, scientists have found. The study found a dramatic increase in the exchange of campylobacter strains between wild birds and chickens as farming has intensified, creating the ideal conditions for the bacteria to mix, spread and acquire new traits. There has also been a rise in antimicrobial resistance traits in circulating strains, raising concerns that serious illness in people will be more difficult to treat. Continue reading...
1213086
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 28/07/2026
A new IOI study has revealed that industrial poultry farming has increased the movement of Campylobacter - the world's No. 1 bacterial cause of diarrhoea - between wild birds and poultry, and has created ideal conditions for bacteria to adapt, thrive and spread. Read more👉https://ow.ly/xWfu50Zse8x
022
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 24/07/2026
At our 2026 Early Career Researcher conference, Dorottya Nagy from the University of Oxford gave a flash talk on evaluating the requirements for effective genomic surveillance of E. coli and Klebsiella bloodstream infections. 👉Watch her talk: ow.ly/nXgv50YT86T
010
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 23/07/2026
IOI researchers have secured a £500,000 award from the BBSRC to protect tetracycline antibiotics from #AMR. These funds will enable a new range of biochemical, structural and cellular studies to investigate Tet(X) enzymes in unprecedented detail. Read more 👉https://ow.ly/gNZY50ZpXvX
120
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 21/07/2026
Private antibiotic dispensing in England doubled in 5 years, yet no central database tracks it. Oxford DPhil student Hao Huang is investigating this data gap to inform national policy and strengthen AMR stewardship as NHS faces 400 resistant infections weekly. Read more 👉 ow.ly/R5oU50ZnioN
141
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 17/07/2026
Eight early career researchers across the University of Oxford have been awarded the AMR Knowledge Exchange grant to develop new skills, share their findings with wider audiences and expand their professional network Read more on our website👉https://ow.ly/78xM50ZmrBh #AMR
020
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 16/07/2026
At our 2026 Early Career Researcher conference, Ben Pascoe from the University of Oxford gave a flash talk on how interpretable machine learning models are being used to identify resistance patterns with high accuracy. Watch his talk👉 ow.ly/gAmp50YT81P
021
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 09/07/2026
At our Early Career Researcher conference 2026, Dr Veerle Brans from the University of Oxford presented a flash talk on the use of ultrasound and shockwaves to tackle implant-related orthopaedic infections. Watch the talk on our YouTube channel👉 ow.ly/fBBe50ZlUyt
120
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 07/07/2026
A new paper, based on the IOI's BALANCE study, shows how structural inequalities in antimicrobial resistance (AMR) research create barriers in LMICs, despite international investment. The authors outline how more equitable funding models could help tackle AMR. Read more👉https://ow.ly/iBry50ZkywX
020
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 02/07/2026
At our Early Career Researcher conference 2026, Javier Magide from the Wellcome Sanger Institute gave a flash talk on using deep genomics to provide a quantitative analysis of AMR dynamics for chronic Pseudomonas aeruginosa infections. Watch his talk👉 www.youtube.com/watch?v=QSvhra5DZpA
010
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 25/06/2026
Flash talk video - IOI ECR Conference 2026 Winifred Maduko from the University of St Andrews shared her community-driven evaluation of AMR communication strategies in Nigeria. She was one of the winners of the best flash talk . 👉Watch their talk: www.youtube.com/watch?v=MY5qvGQKsHY
000
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 18/06/2026
At our Early Career Researcher conference 2026, Michelle Yin from the University of Oxford presented a flash talk on conjugative pili and their potential to improve phage therapy against #AMR. 👉Watch her talk: www.youtube.com/watch?v=LCsM3vlNaG0
010
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 15/06/2026
Last week, ITV News visited the IOI to learn about our work to protect antibiotics from antimicrobial resistance (#AMR). They spoke to surgeon David Sweetnam about the scale of the crisis, and Dr Alistair Farley about drug discovery at the IOI. Watch the segment here👉 ow.ly/ACim50ZbJGv
ow.ly
Oxford scientists work to find new antibiotics as drug resistance concerns grow - Latest From ITV News
Watch the latest from ITV News - The city was at the forefront of developing penicillin 100 years ago.
130
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 11/06/2026
At our Early Career Researcher conference 2026, PhD student Alyaa Al-Tabtabai from King's College London shared her research on hydrogen sulphide gas and cold plasma as novel delivery systems for treating topical fungal infections. 👉Watch her talk: youtu.be/6Ac6nApwna0?si=3GySBu7ygyQ…
000
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 09/06/2026
IOI DPhil student Maria Nieto-Rosado is investigating how drug-resistant Klebsiella pneumoniae survive on surfaces like medical equipment and furniture in hospitals in LMIC countries . Her PhD research aims to update global infection prevention guidelines. Read more👉https://ow.ly/zzWi50Z9eV5
120
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 05/06/2026
At our Early Career Researcher conference 2026, Sid Mookerjee from Brighton and Sussex Medical School shared insights into how AI and digital tools are being developed to optimise how we monitor and treat infections in real-time. 👉 Watch the full talk: ow.ly/8oKf50YT7ln
010
Reposted by Ineos Oxford Institute for antimicrobial research
Oxford Medical Sciences Division @medsci.ox.ac.uk · 04/06/2026
NEWS: New type of inhibitor could help tackle resistance against ‘last-resort’ antibiotics Read about this study from @ineosoxford.bsky.social 
medsci.ox.ac.uk
New type of inhibitor could help tackle resistance against ‘last-resort’ antibiotics
Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) have identified a new class of molecule that could help protect ‘last-resort’ antibiotics from bacterial resistance, and reduce the amount of antibiotics needed to treat infections by up to 32 times.
033
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 04/06/2026
Researchers from Ineos Oxford Institute for antimicrobial research (IOI) have discovered that cephalosporins, a widely used class of antibiotics, can block a key enzyme that SARS-CoV-2 needs to replicate - 120 compounds were investigated. 👉Read more: ow.ly/xGMm50Z73To
183
Reposted by Ineos Oxford Institute for antimicrobial research
University of Oxford @ox.ac.uk · 04/06/2026
NEW: Researchers from @ineosoxford.bsky.social have identified a new class of molecule that could help protect ‘last-resort’ antibiotics from bacterial resistance, and reduce the amount of antibiotics needed to treat infections by up to 32 times ⬇️ bit.ly/4x2wMEo
Close-up photograph of an antibiotic susceptibility test in a laboratory. A white antibiotic disc labelled “CTX 30” sits at the centre of a bacterial culture plate, surrounded by a clear circular zone where bacterial growth has been inhibited. A dark blue banner at the bottom contains the text: “New type of inhibitor could help tackle resistance against ‘last-resort’ antibiotics” alongside University of Oxford branding.
12311
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 02/06/2026
Researchers from the IOI and Oxford AMR Network published four new studies related to antibiotic drug discovery in May, including investigations into the enzymes behind antimicrobial resistance, and the inhibitor drugs that stop them. Find out more👉https://www.ineosoxford.ox.ac.uk/research
020
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 28/05/2026
At our Early Career Researcher Conference 2026, Dr Daire Cantillon from Liverpool School of Tropical Medicine discussed opportunities and barriers researchers face when navigating academic-industry collaborations. Watch the talk here 👉https://www.youtube.com/watch?v=Cc1JH8DBHRM
020
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 26/05/2026
Scientists at the IOI and Oxford's Department of Pharmacology have identified a protein in MRSA bacteria that helps it develop antimicrobial resistance (#AMR). This new research will allow them to develop new ways of slow the development of AMR. Read more👉https://ow.ly/HbUR50Z2ABu
161
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 21/05/2026
At our 2026 Early Career Researcher conference, Dr Melissa Haines, Clinical Lead at the Becky Mayer Centre for Phage Research, talked about the potential of phage therapy, and translating bench science into clinical treatments. 👉Watch the talk: www.youtube.com/watch?v=DxKreYk0I4o
010
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 20/05/2026
Can resistant bacteria protect their neighbours from antibiotics? New review explore the concept of ’social resistance’ and if antibiotic-resistant enzymes can shield surrounding bacteria, that may not be resistant themselves. 👉Read the full article: ow.ly/Y7G450Z1vMg
151
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 19/05/2026
IOI scientists have found a new inhibitor molecule to protect last-resort antibiotics from #AMR. This compound blocks antibiotic-degrading enzymes by trapping water around inside them, reducing the amount of antibiotic needed to treat infections by up to 32x. Read more👉https://ow.ly/Cees50Z15BE
020
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 18/05/2026
In March, IOI DPhil students took part in the Curiosity Cube programme, helping over 450 school children explore key microbiology concepts like enzymes, DNA, and bacteria through interactive learning experiences. Read more about outreach at the IOI👉https://ow.ly/zSNv50YSkPh #SPARKCuriosity #AMR
Group of six volunteers with the Curiosity Cube programme, including two DPhil students from the Ineos Oxford Institute for antimicrobial research (IOI), wearing bright green shirts standing and leaning around a purple mobile unit with a ramp on a sunny day.
160
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 15/05/2026
IOI researchers have found that SmTetX - a recently discovered enzyme which was thought to degrade tetracycline antibiotics - may not contribute to #AMR. Clarifying which enzymes cause AMR is crucial for global tracking, and finding new drug targets. Read more👉 ow.ly/JJO350YZ1Ht
Researcher Matthew Beech conducting laboratory tests at the Ineos Oxford Institute for antimicrobial research (IOI). Matt is wearing blue gloves with a white coat and lab goggles. In a red circle, there is text that says "IOI study challenges proposed role of enzyme in tetracycline resistance"
140
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 14/05/2026
Speaker video - IOI ECR Conference 2026 Dr Norman van Rhijn from Manchester University delivered a talk on how climate change is directly influencing fungal pathogens and the rise of antifungal resistance. 👉Watch their full talk: www.youtube.com/watch?v=oGQECiMxqmI
020
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 12/05/2026
In LMICs, microbiological lab tests can be expensive to access. Oxford DPhil Forhad Chowdhury tested a new approach using procalcitonin, a biomarker that shows when infections have cleared. With this, course length could be cut down by around 3 days. 🔗https://ow.ly/acyj50YRNmM
030
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 07/05/2026
Dr Jeannine Hess from The Francis Crick Institute & King's College London presented her work at our Early Career Researcher conference, on using metal complexes as innovative chemical tools for antimicrobial drug discovery. 👉Watch the talk: www.youtube.com/watch?v=BOx-hFAiuWw #IOIECR26
010
Reposted by Ineos Oxford Institute for antimicrobial research
Gavi @gavi.org · 05/05/2026
As antibiotic resistance grows, scientists are turning to bacteriophages: viruses that target harmful bacteria without wiping out beneficial microbes. Discover more about these incredible microscopic predators via @ConversationUK: bit.ly/3OG5nHd
021
Reposted by Ineos Oxford Institute for antimicrobial research
WHO @who.int · 05/05/2026
Clean hands save lives. 🤝 Infection prevention and control action, including #HandHygiene, can reduce the risk of health care-associated infections by up to 70%. Let’s stop the spread of germs and reduce avoidable infections!
Hand hygiene stops the spread of harmful germs. It saves lives-yours, mine, and many more. Image shows illustration of a pair of hands with a soap bottle, against a blue background.
811339
Reposted by Ineos Oxford Institute for antimicrobial research
ASM @asm.org · 04/05/2026
#MicrobiologyMonday: Reusing treated wastewater for irrigation could ease water shortages—but spore‑forming pathogens like C. diff can survive treatment & persist in soils, raising concerns about crop contamination & antibiotic resistance. #AppEnvMicro: asm.social/2VC
Event diagram summarizing potential routes of transfer of Clostridioides difficile and Clostridium perfringens fromwastewater to consumers via foodstuffs
142
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 05/05/2026
Millions globally are affected by wounds with biofilms - slimy layers that defend bacteria from antibiotics. Victor Choi (Department of Engineering Science, University of Oxford) uses ultrasound to break biofilms, and the IOI helped him to test his work beyond the lab. 🔗https://ow.ly/QPUO50YRCnn
130
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 30/04/2026
Speaker video - IOI ECR Conference 2026 Dr Jennifer Schneider, CEO of Centauri Therapeutics delivered the keynote address at our ECR conference on “Doing the work to improve outcomes for those with difficult to treat infections”. 👉 Watch full talk: ow.ly/AVQk50YRBMQ
010
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 28/04/2026
1 in 3 infections in some LMICs show signs of #AMR, but most data still comes from high-income countries. That's why BALANCE, led by Dr Refath Farzana, is gathering data from >67,000 patients worldwide, providing a global view of resistance. Read more on our website👉https://ow.ly/IQrn50YQBb7
Dr Refath Farzana, scientific lead at the Ineos Oxford Institute for antimicrobial research (IOI), operates a large device in the IOI's labs. She is wearing a white coat and blue gloves, and is lifting a small blue object out from inside a large basin. The text says "IOI Spotlight- Tackling the global imbalance in AMR data with Dr Refath Farzana, BALANCE project lead at the IOI"
130
Ineos Oxford Institute for antimicrobial research @ineosoxford.bsky.social · 24/04/2026
IOI researchers and collaborators presented 45+ posters & talks at the ESCMID Global conference in Munich - spanning bacteriophages, drug discovery & more. Huge thank you to everyone who represented the IOI this year👏. Explore all topics on our website 👉https://ow.ly/TKk350YOA6n
000